These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2788659)

  • 41. A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.
    Zocchi MR; Bottino C; Ferrini S; Moretta L; Moretta A
    J Exp Med; 1987 Aug; 166(2):319-26. PubMed ID: 3598463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.
    Fierro MT; Liao XS; Lusso P; Bonferroni M; Matera L; Cesano A; Lista P; Arione R; Forni G; Foa R
    Leukemia; 1988 Jan; 2(1):50-4. PubMed ID: 3257539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
    Atzpodien J; Gulati SC; Shimazaki C; Bührer C; Oz S; Kwon JH; Kolitz JE; Clarkson BD
    Oncology; 1988; 45(6):437-43. PubMed ID: 3263598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysis of human monocytes by lymphokine-activated killer cells.
    Djeu JY; Blanchard DK
    Cell Immunol; 1988 Jan; 111(1):55-65. PubMed ID: 2827894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes.
    Sone S; Inamura N; Nii A; Ogura T
    Int J Cancer; 1988 Sep; 42(3):428-34. PubMed ID: 3262092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
    Vujanovic NL; Herberman RB; Maghazachi AA; Hiserodt JC
    J Exp Med; 1988 Jan; 167(1):15-29. PubMed ID: 3257251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
    Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
    Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ; Golub SH
    J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and expansion of human lymphokine-activated killer cells: implications for the immunotherapy of cancer.
    Skibber JM; Lotze MT; Uppenkamp I; Ross W; Rosenberg SA
    J Surg Res; 1987 Jun; 42(6):613-21. PubMed ID: 3295393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experimental studies on induction of various lymphokine-activated killer cells using recombinant interleukin 2].
    Takao H; Saji S; Sugiyama Y; Tachibana S; Goshima H; Morita T; Sakata K
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):646-54. PubMed ID: 3261830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.
    Sone S; Utsugi T; Nii A; Ogura T
    J Natl Cancer Inst; 1988 May; 80(6):425-31. PubMed ID: 3130488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal methods for generating expanded lymphokine activated killer cells capable of reducing established murine tumors in vivo.
    Lafreniere R; Rosenstein MS; Rosenberg SA
    J Immunol Methods; 1986 Nov; 94(1-2):37-49. PubMed ID: 2878049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
    Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
    Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes.
    Nishimura T; Yagi H; Uchiyama Y; Hashimoto Y
    Cell Immunol; 1986 Jun; 100(1):149-57. PubMed ID: 2874890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
    Subauste CS; Dawson L; Remington JS
    J Exp Med; 1992 Dec; 176(6):1511-9. PubMed ID: 1460415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cells.
    Panayotides P; Porwit A; Sjögren AM; Wasserman J; Reizenstein P
    Eur J Haematol; 1988 Apr; 40(4):362-7. PubMed ID: 3259192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.